Manipal Health Enterprises Ltd which operates the Manipal Hospitals network has fully redeemed ₹5,310 crore worth of outstanding listed non-convertible debentures (NCDs) using proceeds from its recently completed Initial Public Offering (IPO).The NCDs were issued by the company’s wholly owned subsidiary, Manipal Hospitals Private Limited. The debt repayment was one of the stated objectives of the IPO, as disclosed in the company’s prospectus dated July 31, 2026.
According to Manipal Hospitals, the redemption covered the outstanding NCD principal, accrued interest and applicable prepayment or early-redemption costs. The company said the repayment was carried out using the relevant portion of the IPO proceeds in line with the objects specified in its offer documents. The move represents a significant step in Manipal Health’s post-listing capital-allocation strategy. By retiring the ₹5,310 crore NCD obligation the company expects to reduce its interest burden and create additional financial headroom for future investments.
Sameer Agarwal, Chief Financial Officer, Manipal Health Enterprises, said the full redemption was an important milestone following the company’s listing. He said deploying IPO proceeds towards debt repayment would help strengthen the balance sheet, lower interest costs and provide greater flexibility for investments in hospital capacity, technology and talent.
The debt reduction comes at a time when Manipal Hospitals is continuing to expand its hospital network and invest in healthcare infrastructure and technology. Lower financial obligations could provide the company with greater flexibility in allocating capital between expansion, technology upgrades and other operational priorities.The debt repayment follows a strong first quarter performance for FY27. Manipal Health reported revenue of ₹3,091 crore in Q1 FY27, representing a 38.1% year-on-year increase. EBITDA increased 26.4% to ₹749 crore while reported profit after tax stood at ₹243 crore. Adjusted PAT rose 30.9% to ₹332 crore, according to company-reported figures.
The repayment marks a shift in the company’s post-IPO financial position, with a substantial portion of the capital raised being used for the specific purpose outlined to investors reducing debt. The lower NCD burden can potentially reduce finance costs and improve the company’s capacity to deploy capital towards new hospitals, additional beds, medical technology and healthcare talent, subject to its future investment plans.
For India’s private hospital sector, the development also highlights how large healthcare chains are increasingly using capital-market funding not only to support expansion but also to strengthen their balance sheets and optimise capital structures.